0000000000246689

AUTHOR

Th. Büchner

showing 2 related works from this author

Salvage Therapy of Adult ALL

1996

In a first study (1986 to 1992) the German Relapsing ALL Study Group (GRALLSG) has treated 67 adult patients with a first relapse of ALL. A first phase of induction consisted of vindesine, daunorubicin, asparaginase, and prednisone, a second phase of high-dose cytosine-arabinoside (Hd ara-C) and VP16. Results: 45 CR, 2 PR, 13 failures, 7 early death. 25 patients received a BMT. 10 had an allogeneic BMT in CR, 5 after another relapse or with refractory disease. Of 10 with autologous BMT 8 have been in 2nd CR. Only 4 of all 67 patients are surviving without relapse: One after unrelated BMT (36+mo), two after autologous BMT in 2nd CR (46+, 64+mo), and one after chemotherapy (61+mo). One patien…

medicine.medical_specialtyChemotherapyIfosfamidebusiness.industrymedicine.medical_treatmentSalvage therapymedicine.diseaseGastroenterologyPrednisoneAcute lymphocytic leukemiaInternal medicinemedicinePrednisoloneVindesineIdarubicinbusinessmedicine.drug
researchProduct

Phase I/II Trial of High-Dose Cytosine Arabinoside and Mitoxantrone in Adult Refractory Acute Myeloid Leukemia

1987

In spite of a high initial response rate of 60% –80% the vast majority of adult patients with acute myeloid leukemia (AML) still cannot be cured of the disease and ultimately die from recurrent and refractory leukemia. The development of new therapeutic approaches and of more effective drugs therefore seems warranted.

OncologyMitoxantronemedicine.medical_specialtyAcute leukemiabusiness.industryMyeloid leukemiaDiseasemedicine.diseaseLeukemiachemistry.chemical_compoundRefractorychemistryhemic and lymphatic diseasesInternal medicinemedicineCytarabinebusinessCytosinemedicine.drug
researchProduct